NCT05132101已完成不适用
Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a 1st Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 2,758
- 试验地点
- 1
- 主要终点
- Total treatment duration and cycle for Palbociclib
研究概览
简要总结
The objective of this study is to evaluate the real-world prescription patterns of Palbociclib in breast cancer (BC) patients who were treated with Palbociclib in combination with AI as a 1st line of therapy using the national health insurance claims data in South Korea.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients who were prescribed with palbociclib in combination with AI for at least 1 cycle during the index period
- •Patients who were diagnosed with BC during the index period
排除标准
- •Prescribed with palbociclib during 12-month period preceding the index date
结局指标
主要结局
Total treatment duration and cycle for Palbociclib
时间窗: From index date (Index date: 06 Nov 2012 to 30 Sep 2020) to the end date of last palbociclib prescription (maximum of 34.8 months from the index date)
次要结局
- Assessment on dose modification of Palbociclib as first line of therapy in BC patients in real-world setting.(From the index date (Index date: 06 Nov 2012 to 30 Sep 2020) to the time of reduction or increase in the dose given in the subsequent Palbociclib prescription (up to 30 Sep 2020))
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other OrgansBreast CancerNCT06003114Pfizer472
招募中
不适用
The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR TabDiabetes Mellitus, Type 2NCT06188234Hanlim Pharm. Co., Ltd.3,000
已完成
不适用
Real-World Effectiveness of Palbociclib in Combination With an Aromatase InhibitorMetastatic Breast CancerNCT05361655Pfizer2,888
已完成
不适用
Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart DiseaseAtrial FibrillationNCT06239402Istituti Clinici Scientifici Maugeri SpA394
已完成
不适用
A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in AustraliaBreast NeoplasmsNCT06624020Pfizer1,128